Innova Horizon AB

High Coast Longevity Intelligence is currently being developed through Innova Horizon AB.

Innova Horizon AB provides the organizational base for the early development of the platform, including concept development, digital structure, product planning, intellectual property work, partnership dialogue and long-term platform building.

At this stage, High Coast Longevity Intelligence is an early project. The structure is intentionally flexible while the platform, product areas, diagnostic direction and partner network are being developed.

Nordic bilberry

Organizational home

Innova Horizon AB functions as the current company structure behind High Coast Longevity Intelligence.

The company provides a practical framework for:

  • platform development
  • website and communication structure
  • product concept development
  • Nordic Bioactives development
  • intellectual property work
  • partnership discussions
  • future commercial and research activities

As the project grows, the organizational structure may evolve further.

Platform development

High Coast Longevity Intelligence is being developed as more than a content site.

The ambition is to build a platform that can connect:

  • longevity and healthspan concepts
  • diagnostics and biomarker testing
  • Nordic bioactive products
  • structured health programs
  • research and evidence communication
  • digital health and follow-up
  • hospitality and place-based experiences
  • regional development in the High Coast

Innova Horizon AB supports this development during the early phase.

Background in health innovation

The work behind High Coast Longevity Intelligence builds on previous experience with preventive health concepts, laboratory testing, biomarker packages, digital health positioning and product development.

Earlier work has included concepts for women’s and men’s health testing, including larger biomarker panels and structured health assessment models.

This background is relevant because High Coast Longevity Intelligence is being developed around the connection between testing, interpretation, products, programs and long-term follow-up.

Intellectual property and development work

Innova Horizon AB is also connected to broader health intelligence development work within the High Coast Health Intelligence Institute ecosystem.

This includes early-stage intellectual property activity, including United States provisional patent filings related to biological monitoring, diagnostic interpretation and structured analysis of health-related data.

The broader founder background also includes a granted United States patent where Roger Svensson is one of the named inventors, related to biological test selection and diagnostic decision support.

This reflects a longer development direction around health intelligence, biological testing, interpretation and decision-support systems.

Nordic Bioactives and product pipeline

A key part of the current development work is the Nordic Bioactives direction.

This includes product concepts based on Nordic berries, polyphenols, bioactive ingredients and targeted support areas such as longevity, cellular health, skin, circulation, microbiome and men’s health.

The product pipeline is being developed gradually and is intended to connect with the broader platform logic: products should be part of structured use cases, not isolated claims.

Current phase

High Coast Longevity Intelligence is still in an early development phase.

Current work includes:

  • building the website and brand structure
  • developing the shop and product pipeline
  • preparing future health testing presentation
  • connecting longevity with diagnostics and programs
  • strengthening the High Coast positioning
  • developing partnership material
  • aligning the project with the broader Institute ecosystem

The role of Innova Horizon AB is to provide the practical company base while this structure is being built.

Summary

Innova Horizon AB is the current organizational home for High Coast Longevity Intelligence.

The company supports early development across platform strategy, products, diagnostics, intellectual property, communication and partnerships.

The project is still evolving, but the direction is clear: to build a long-term platform where longevity, diagnostics, Nordic bioactives, programs and place-based health development can connect.